Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Finasteride improved hidradenitis suppurativa in kids without side effects.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

More research is needed to understand hair and scalp disorders in people with skin of color.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Excessive vitamin A intake caused severe health issues that mostly resolved after stopping the intake.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.